| Net revenues | |
| Cost of sales | 196.27M |
| Gross profit | 269.18M |
| Selling, general and administrative | 128.85M |
| Research and development | 34.45M |
| Donations to research foundations | |
| Amortization of acquired intangible assets | |
| Total operating expenses | 175.04M |
| Income from operations | 94.15M |
| Interest income, net | |
| Other, net (note 12) | 1.27M |
| Total other income, net | -1.22M |
| Income before income taxes | |
| Income taxes (note 13) | 16.82M |
| Net income | 76.11M |
| Basic earnings per share | 0.54 |
| Diluted earnings per share (note 2-j) | 0.54 |
| Basic weighted average shares outstanding | 140.79M |
| Diluted weighted average shares outstanding | 142.09M |